Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Volume

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Sep 26, 2022 3:51pm

86 Views

Post# 34987516

RE:RE:RE:RE:RE:RE:RE:Volume

Qwerty22 I am sorry but due to supply chain disruptions my doctor advised me to keep all therapeutic & celebratory fermented liquids close by.

qwerty22 wrote:
I'd still drink out-of-date champagne. Send it to me.

Lee430 wrote: Thera, Power of the mighty retail investor, Pleeeze are you paying attention!...I wont breath a sigh of relief until we are holding above $5 again, hopefully soon as I am running low on Tequila and my celebratory Champange is past the expiration date ;->

qwerty22 wrote:
Just eyeballing the chart it looks like the most daily volume YTD.

stephanedodier wrote: I hope it was not just a pump and dump ....